While the NAT2 isoenzyme has a major role in the metabolism of xenobiotics, including therapeutic drugs and carcinogens, growing evidence supports an additional role for NAT1 in physiological processes (notably folate and methionine metabolism) and cancer cell biology. This evidence concerns the gene NAT1 and cancer.